@article{article, title  = {{A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)}},

 url = {{https://eprints.whiterose.ac.uk/101660/ }},

 year = {{2016}},

 month = {{5}},

 author = {{Powles T and Brown J and Larkin J and Jones R and Ralph C and Hawkins R and Chowdhury S and Boleti E and Bhal A and Fife K and Webb A et al}},

 doi = {{10.1093/annonc/mdw014}},

 volume = {{27}},

 journal = {{Annals of Oncology}},

 issue = {{5}},

 pages = {{880-886}},

 note = {{Accessed on 2024/12/22}}}